We have successfully completed the petition period and now call upon you to submit your vote (for/against) the entire slate before Saturday, Aug. 15, 2026.

As a reminder, the Board Nominating Committee, chaired by ATS Past President M. Patricia Rivera MD, ATSF, conducted a rigorous vetting of ATS members who responded to the call for nominations. The vetting process included submission of a letter of interest, written responses to specific questions, letters of support, virtual interview, feedback from colleagues and committee members, and input from staff. The committee also evaluated the candidates based on the competency framework - Leadership/Strategy, Financial Acumen, Innovative Thinking, Engagement and ensuring overall Diversity and Cultural Fit.

In accordance with the bylaws, the ATS Board of Directors consists of 15 at-large directors, one public member (Public Advisory Roundtable) who serve staggered terms, and the CEO as an ex-officio, non-voting member.

We are pleased to present the following slate for your consideration: